Neura Robotics has disclosed Neuron AI, a perception-language-action model that fuses 3D vision, touch, force sensing, audio and physical state into a single control layer, backed by $1.4bn in capital. The same week, Chinese authorities issued management rules for police robots days after station-level deployment began, covering safety, oversight and data use.
The two events mark the opposite ends of the same curve. Neura is betting that a full-stack embodied foundation model, not hardware alone, becomes the defensible asset; the capital figure implies investors are pricing model capability over unit sales. China's rules, arriving almost simultaneously with deployment, suggest regulators now treat embodied machines as operational infrastructure rather than prototypes.
Commercial data points remain uneven. Agile Robots reported EUR 300m revenue for 2025 and a EUR 600m target for 2026, but 85 to 90 percent of that growth originates in acquired business, which indicates integration revenue and organic robotics revenue should be read separately. Humanoid rental listings in China span RMB 289 to RMB 2,000 per day across five products, a spread wide enough to show pricing has not settled.
Research and reimbursement move on separate tracks. HKUST's EmArm extends soft optical tactile skin across the whole arm, widening the contact surface a robot can safely use; medical exoskeleton rehabilitation training has entered insurance pilots in Beijing, Shanghai, Jiangsu and Zhejiang, giving clinical adoption a payment route rather than a subsidy. RoboParty's fully open-source RP1 lowers the build barrier for research teams.
Watch two variables: whether Neura converts capital into shipped units before Chinese integrators consolidate, and whether insurance pilots generate utilization data that justifies reimbursement expansion.